$288+ Bn Global Nanomedicine Market is Expected to Grow at a CAGR of over 8.9% During 2022-2028 | Vantage Market Research
08 juin 2022 05h30 HE
|
Vantage Market Research
WASHINGTON, June 08, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Nanomedicine Market finds that the increasing prevalence of chronic diseases is expediting...
Nanomedicine Market (2021-2026): Global Key Competitors Include Abbott Laboratories, Luminex Corporation, Merck & Co, Nanobiotix and Novartis
29 déc. 2021 04h53 HE
|
Research and Markets
Dublin, Dec. 29, 2021 (GLOBE NEWSWIRE) -- The "Nanomedicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's...
Global Nanomedicine Market Report 2021
02 nov. 2021 10h08 HE
|
Research and Markets
Dublin, Nov. 02, 2021 (GLOBE NEWSWIRE) -- The market is expected to grow to reach $361.44 billion in 2025 according to the "Nanomedicine Global Market Report 2021: COVID-19 Growth and Change" report...
Cello Therapeutics’ Platelet Membrane-Coated Nanoparticles Offer a Novel Platform for the Delivery of Immunotherapy in Cancer Treatment
31 mars 2021 22h57 HE
|
Cello Therapeutics, Inc.
SAN DIEGO, March 31, 2021 (GLOBE NEWSWIRE) -- Solid tumors comprise about 90% of all newly diagnosed cancer cases and cancer deaths according to an annual report from the National Cancer Institute....
Karamedica Announces National Institute on Aging Grant to Continue Development of Microparticle Therapy for Cerebral Amyloid Angiopathy
15 déc. 2020 07h55 HE
|
Karamedica, Inc.
RALEIGH, N.C., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Karamedica, Inc. recently received a $2.5 million Small Business Innovative Research (SBIR) Phase II grant from the National Institute on Aging to...
Arch Therapeutics, Inc. to Present at the Virtual Investor Fireside Chat Series
08 juin 2020 07h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., June 08, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel wound care and biosurgical devices, today announced that...
UPDATE - Arch Therapeutics Provides Corporate Update at the 2nd Annual LD Micro Big Apple Conference in Manhattan, NY
07 oct. 2019 15h59 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Oct. 07, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, is...
Arch Therapeutics Provides Corporate Update at the 2nd Annual LD Micro Big Apple Conference in Manhattan, NY
07 oct. 2019 11h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Oct. 07, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, is...
Atlas Nanotech of Guadalajara to begin alliance with European Nano Medical S.R.O.
27 juin 2019 00h14 HE
|
COSTAS Inc.
GUADALAJARA, Mexico, June 27, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – CSSI (Costas Inc.) DBA Atlas Nanotech has entered an accord with Nano Medical S.R.O. of the Czech Republic. The first...
COSTAS Inc. (CSSI) Acquires Medical Nanotechnology Company, Appoints New Management and Board Members
06 juin 2019 01h08 HE
|
COSTAS Inc.
LAS VEGAS, June 06, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – COSTAS,Inc. (OTC: CSSI), announces its acquisition of Atlas Nanotech (formerly known as Nano Creaciones SAPI de CV) in an all-stock...